Tag: mepolizumab
Biologics in Severe Asthma: How Anti-IgE and Anti-IL-5 Therapies Change the Game
Anti-IgE and anti-IL-5 biologics are transforming severe asthma care by targeting specific immune pathways. Learn how omalizumab, mepolizumab, and benralizumab reduce flare-ups, cut steroid use, and restore quality of life for those who don’t respond to standard treatments.
read morerecent posts
Fake generic drugs are a growing global threat, infiltrating supply chains through loopholes in regulation, online sales, and grey market distribution. Learn how they’re made, how they get into pharmacies, and what you can do to protect yourself.
Published ON: 19 MarBioequivalence testing for combination products like FDCs, inhalers, and topical creams is far more complex than for single-drug generics. Regulatory, technical, and financial hurdles delay affordable access to life-saving medications.
Published ON: 13 MarPhysicians prescribing generic medications now face rising legal liability as federal rulings shield drug manufacturers from lawsuits. Learn how to protect yourself with proper documentation and prescribing practices.
Published ON: 10 MarLearn the critical difference between medication side effects and adverse drug reactions - why confusing them can lead to unnecessary panic, wrong decisions, and even dangerous health outcomes. Clear, science-backed explanation for patients and caregivers.
Published ON: 6 MarNasal congestion from overused decongestant sprays is common and reversible. Learn how rebound congestion works, why stopping the spray is the only cure, and what actually helps you recover - backed by clinical evidence.
Published ON: 5 Mar